Earnings Per Share, Basic of MADRIGAL PHARMACEUTICALS, INC. from 31 Dec 2010 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD/shares
- Description
- The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
- Summary
-
MADRIGAL PHARMACEUTICALS, INC. quarterly and annual Earnings Per Share, Basic in USD/shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
- MADRIGAL PHARMACEUTICALS, INC. Earnings Per Share, Basic for the quarter ending 31 Dec 2025 was -2.55, a 2% decline year-over-year.
- MADRIGAL PHARMACEUTICALS, INC. Earnings Per Share, Basic for the twelve months ending 31 Dec 2025 was -12.85, a 41% increase year-over-year.
- MADRIGAL PHARMACEUTICALS, INC. annual Earnings Per Share, Basic for 2025 was -12.85, a 41% increase from 2024.
- MADRIGAL PHARMACEUTICALS, INC. annual Earnings Per Share, Basic for 2024 was -21.9, a 9.6% decline from 2023.
- MADRIGAL PHARMACEUTICALS, INC. annual Earnings Per Share, Basic for 2023 was -19.99, a 16% decline from 2022.
- Source SEC data
- View on sec.gov
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)
MADRIGAL PHARMACEUTICALS, INC. Quarterly Earnings Per Share, Basic (USD/shares)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -12.85 | -2.55 | -0.05 | -2% | 01 Oct 2025 | 31 Dec 2025 | 10-K | 19 Feb 2026 | 2025 | FY |
| Q3 2025 | -12.8 | -5.08 | -0.16 | -3.3% | 01 Jul 2025 | 30 Sep 2025 | 10-Q | 04 Nov 2025 | 2025 | Q3 |
| Q2 2025 | -12.64 | -1.9 | +5.2 | +73% | 01 Apr 2025 | 30 Jun 2025 | 10-Q | 05 Aug 2025 | 2025 | Q2 |
| Q1 2025 | -17.84 | -3.32 | +4.06 | +55% | 01 Jan 2025 | 31 Mar 2025 | 10-Q | 01 May 2025 | 2025 | Q1 |
| Q4 2024 | -21.9 | -2.5 | +3.18 | +56% | 01 Oct 2024 | 31 Dec 2024 | 10-K | 19 Feb 2026 | 2025 | FY |
| Q3 2024 | -25.08 | -4.92 | +0.42 | +7.9% | 01 Jul 2024 | 30 Sep 2024 | 10-Q | 04 Nov 2025 | 2025 | Q3 |
| Q2 2024 | -25.5 | -7.1 | -2.41 | -51% | 01 Apr 2024 | 30 Jun 2024 | 10-Q | 05 Aug 2025 | 2025 | Q2 |
| Q1 2024 | -23.09 | -7.38 | -3.15 | -74% | 01 Jan 2024 | 31 Mar 2024 | 10-Q | 01 May 2025 | 2025 | Q1 |
| Q4 2023 | -19.94 | -5.68 | -0.7 | -14% | 01 Oct 2023 | 31 Dec 2023 | 10-K | 28 Feb 2024 | 2023 | FY |
| Q3 2023 | -19.24 | -5.34 | -0.59 | -12% | 01 Jul 2023 | 30 Sep 2023 | 10-Q | 31 Oct 2024 | 2024 | Q3 |
| Q2 2023 | -18.65 | -4.69 | -0.55 | -13% | 01 Apr 2023 | 30 Jun 2023 | 10-Q | 07 Aug 2024 | 2024 | Q2 |
| Q1 2023 | -18.1 | -4.23 | -0.87 | -26% | 01 Jan 2023 | 31 Mar 2023 | 10-Q | 07 May 2024 | 2024 | Q1 |
| Q4 2022 | -17.23 | -4.98 | -1.2 | -32% | 01 Oct 2022 | 31 Dec 2022 | 10-K | 28 Feb 2024 | 2023 | FY |
| Q3 2022 | -16.03 | -4.75 | -0.96 | -25% | 01 Jul 2022 | 30 Sep 2022 | 10-K | 28 Feb 2024 | 2023 | FY |
| Q2 2022 | -15.07 | -4.14 | -0.42 | -11% | 01 Apr 2022 | 30 Jun 2022 | 10-K | 28 Feb 2024 | 2023 | FY |
| Q1 2022 | -14.65 | -3.36 | -0.04 | -1.2% | 01 Jan 2022 | 31 Mar 2022 | 10-K | 28 Feb 2024 | 2023 | FY |
| Q4 2021 | -14.61 | -3.78 | 01 Oct 2021 | 31 Dec 2021 | 10-K/A | 03 Mar 2023 | 2022 | FY | ||
| Q3 2021 | -3.79 | 01 Jul 2021 | 30 Sep 2021 | 10-K/A | 03 Mar 2023 | 2022 | FY | |||
| Q2 2021 | -3.72 | 01 Apr 2021 | 30 Jun 2021 | 10-K/A | 03 Mar 2023 | 2022 | FY | |||
| Q1 2021 | -3.32 | 01 Jan 2021 | 31 Mar 2021 | 10-K/A | 03 Mar 2023 | 2022 | FY |
MADRIGAL PHARMACEUTICALS, INC. Annual Earnings Per Share, Basic (USD/shares)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | -12.85 | +9.05 | +41% | 01 Jan 2025 | 31 Dec 2025 | 10-K | 19 Feb 2026 | 2025 | FY |
| 2024 | -21.9 | -1.91 | -9.6% | 01 Jan 2024 | 31 Dec 2024 | 10-K | 19 Feb 2026 | 2025 | FY |
| 2023 | -19.99 | -2.76 | -16% | 01 Jan 2023 | 31 Dec 2023 | 10-K | 19 Feb 2026 | 2025 | FY |
| 2022 | -17.23 | -2.6 | -18% | 01 Jan 2022 | 31 Dec 2022 | 10-K | 26 Feb 2025 | 2024 | FY |
| 2021 | -14.63 | -1.54 | -12% | 01 Jan 2021 | 31 Dec 2021 | 10-K | 28 Feb 2024 | 2023 | FY |
| 2020 | -13.09 | 01 Jan 2020 | 31 Dec 2020 | 10-K/A | 03 Mar 2023 | 2022 | FY | ||
| 2011 | -1 | -0.07 | -7.5% | 01 Jan 2011 | 31 Dec 2011 | 10-K | 22 Feb 2012 | 2011 | FY |
| 2010 | -0.93 | 01 Jan 2010 | 31 Dec 2010 | 10-K | 22 Feb 2012 | 2011 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.